Good guesses although I don't think NuSkin has been a
Good guesses although I don't think NuSkin has been a customer for awhile. I don't remember if they were ever an app customer, but their current apps as a bunch of issues.
But don't worry, if you are a Nu Skin app user and need support you can email that at nuskindsp@gmail.com
I know what you are thinking, what developing company can't afford a $10/yr domain? Yeah, I was thinking 1000 liner dude too.
The customer signed up for Verb about 6 months ago so Shaklee would fit the bill.
Rory talked about this VerbLIVE customer on the last conference call 5 weeks ago.
"One of the first customers to whom we offered an extended free trial of verbLIVE has now become our largest subscriber yet, that we expect to generate up to $1 million a year of SaaS recurring revenue, much of which we will recognize and report this year."
Let's see if he's able to say more yet.
While the customer is already talking about their new "rocket fuel" for over a month now, sometimes as the vendor, you may want to make an announcement after a launch.
I know when Verb makes customer announcements, I am always poking around looking at how successful the launch went as I assume they are already live and not something they are going to do in the future.
Who'da thunk VerbLIVE selling at $10 a person would generate a million dollar sale with the SaaS gift that keeps on giving?
Oh and if I remember right Shaklee was a good example of a company that WAS doing their technology in-house and swallowed the tough pill and recognized, they can't do it as well as a SaaS company.
That is something I explain A LOT. Why would a company be able to develop an app internally with everything you want for a fraction of what a SaaS company has invested in and continues to invest spreading the cost across many customers.
Nu Skin app is likely developed by a backend provider so maybe a cheap way to go.
It's like taking your car in for repairs and finding the mechanic only has a screw driver and plyers because real tool were to expensive.
It's like going to a neighbors for a BBQ and he is using his fingers to flip burgers
It's like...
as theses customers see their peer companies and competitors revenue grow by using real tool, they likely will be back.
"we had a client decide to save money and not renew and they currently have no app for their sales people, and another go to a far cheaper vanilla app lacking all of the features sales people have come to rely on in our app. We assume these are all COVID-related and we expect some of the larger ones still in business will return as clients, especially drawn by our new verbLIVE and that attribution feature that I spoke about a minute ago."
16
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
MAMMOTION Makes Waves with New Robotic Mowers Gather 'round, folks, because MAMMOTION's making some noise over at IFA 2026 in Berlin. If you've been stuck battling the wild edges of your lawn with a rusty old mower, MAMMOTION might just have the tech to save your weekends—and some grass along the way. This ain't no shiny gadget; it’s a full-on upgrade to lawn war...
Continue Reading
Setting Sail on a Fresh Wave of Luxury It's a whole new world aboard the Oosterdam, folks. Holland America's making waves with the debut of a reimagined Ocean Bar that promises to inject a healthy dose of glamour back into cruising. Forget the stuffy maritime tales of yesteryear; this isn't just a facelift—it's a full-blown Renaissance at sea. A nod to the golden age of...
Continue Reading
Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...
Continue Reading
Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...
Continue Reading
Investors' Trust on Shaky Grounds There it is, staring right back at investors: a securities fraud class action lawsuit against Aardvark Therapeutics. Not exactly the news a shareholder wants to digest over breakfast. If you’ve got skin in the game with Aardvark Therapeutics (NASDAQ: AARD), you might wanna keep reading. Hagens Berman Sobol Shapiro LLP, a name that's no...
Continue Reading
Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...
Continue Reading
The Polynesian Flame Ignites: Tiki Fire Hits Online Games Just when you thought the iGaming world was catching its breath, Aristocrat Interactive throws another curveball. The buzz around their Lightning Link™ series, especially the launch of High Stakes™ in July, took the scene by storm. Now, just in time for another sizzle, they've rolled out Tiki Fire™, bringing...
Continue Reading
Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...
Continue Reading
Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...
Continue Reading
Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...
Continue Reading
Top 5 Most Recently Viewed Articles
Beazer Homes Increases Share Repurchase Initiative Beazer Homes USA, Inc. (NYSE: BZH) has recently communicated a significant acceleration in its share repurchase activity, a move prompted by fluctuations in its share price. The company has approximately $24.8 million remaining under its authorized share repurchase program. This decision illustrates Beazer's commitment to...
Continue Reading
Groundbreaking Narcolepsy Treatment Insights by Takeda In a major development for those living with narcolepsy, Takeda will share important findings about its innovative drug, TAK-861, at Sleep Europe 2024. This conference is a key moment for Takeda to highlight progress in both understanding and treating this complex condition. Narcolepsy typically presents as...
Continue Reading
Understanding Presidents Day Observance by the U.S. Postal Service The U.S. Postal Service (USPS) recognizes Presidents Day as a holiday, meaning that all Post Office locations will be closed, providing a day of rest for employees while encouraging customers to utilize self-service options. This aligns with the USPS commitment to serving communities effectively. Accessing...
Continue Reading
Sidetrade's Prominent Inclusion in Euronext's Tech Leaders Sidetrade, a frontrunner in AI-driven Order-to-Cash applications, recently announced its inclusion in the prestigious Euronext Tech Leaders Index, a pan-European initiative that highlights the continent’s most innovative and rapidly growing tech companies. This initiative, launched in 2022 by Euronext,...
Continue Reading
Cue Biopharma's Financial Highlights and Strategic Changes BOSTON — Cue Biopharma, Inc. (NASDAQ: CUE), a trailblazer in the biopharmaceutical sector, is focused on revolutionizing immunotherapy through its innovative therapies. The company has reported substantial progress in its fourth quarter and full year 2024 financial results, underscoring its commitment to...
Continue Reading